Bharat Electronics, M&M Stocks among top gainers on Nifty 50

In Friday's session, several stocks demonstrated positive movement, securing their positions among the top gainers on the Nifty 50. Among them were Bharat Electronics, M&M, IndusInd Bank, Jio Financial, and Sun Pharma. At 11:00 am, Bharat Elec shares were trading at Rs 377.30, reflecting a gain of 0.83%. M&M shares traded at Rs 3,399.10, up by 0.71%. IndusInd Bank shares were at Rs 771.05, with a rise of 0.47%. Jio Financial shares traded at Rs 324.80, gaining 0.29%, while Sun Pharma shares were at Rs 1,644.90, also up by 0.29%.

Here's a detailed look into the financials of these companies:

Bharat Electronics

Bharat Elec's consolidated financial performance shows consistent growth in revenue and net profit. Here’s an overview of the company’s financial performance:

Consolidated Revenue (Crores):

• Jun 2024: Rs 4,243.57 Crore
• Sep 2024: Rs 4,604.90 Crore
• Dec 2024: Rs 5,770.69 Crore
• Mar 2025: Rs 9,149.59 Crore
• Jun 2025: Rs 4,439.74 Crore

The revenue for the quarter ending June 2025 was Rs 4,439.74 crore, which increased compared to June 2024, when the revenue was Rs 4,243.57 crore.

Consolidated Net Profit (Crores):

• Jun 2024: Rs 780.99 Crore
• Sep 2024: Rs 1,083.88 Crore
• Dec 2024: Rs 1,301.27 Crore
• Mar 2025: Rs 2,121.01 Crore
• Jun 2025: Rs 960.67 Crore

The net profit for the quarter ending June 2025 was Rs 960.67 crore, which increased compared to June 2024, when the net profit was Rs 780.99 crore.

Consolidated EPS:

• Jun 2024: 1.08
• Sep 2024: 1.50
• Dec 2024: 1.79
• Mar 2025: 2.91
• Jun 2025: 1.33

The EPS for the quarter ending June 2025 was 1.33, which increased compared to June 2024, when the EPS was 1.08.

Annual Consolidated Financials (Crores):

The company’s revenue has shown consistent growth, with revenue for the year ending March 2025 at Rs 23,768.75 crore, up from Rs 20,268.24 crore in March 2024. The net profit has also increased, with Rs 5,287.15 crore reported for March 2025, up from Rs 3,943.11 crore in March 2024.

M&M

M&M's consolidated financial performance indicates strong financials. Here’s a summary:

Consolidated Revenue (Crores):

• Jun 2024: Rs 37,217.72 Crore
• Sep 2024: Rs 37,923.74 Crore
• Dec 2024: Rs 41,470.05 Crore
• Mar 2025: Rs 42,599.31 Crore
• Jun 2025: Rs 45,529.19 Crore

The revenue for the quarter ending June 2025 was Rs 45,529.19 crore, which increased compared to June 2024, when the revenue was Rs 37,217.72 crore.

Consolidated Net Profit (Crores):

• Jun 2024: Rs 3,221.34 Crore
• Sep 2024: Rs 2,894.71 Crore
• Dec 2024: Rs 3,317.22 Crore
• Mar 2025: Rs 3,102.48 Crore
• Jun 2025: Rs 3,898.44 Crore

The net profit for the quarter ending June 2025 was Rs 3,898.44 crore, which increased compared to June 2024, when the net profit was Rs 3,221.34 crore.

Consolidated EPS:

• Jun 2024: 29.44
• Sep 2024: 28.43
• Dec 2024: 28.51
• Mar 2025: 29.52
• Jun 2025: 36.58

The EPS for the quarter ending June 2025 was 36.58, which increased compared to June 2024, when the EPS was 29.44.

Annual Consolidated Financials (Crores):

The company’s revenue has shown consistent growth, with revenue for the year ending March 2025 at Rs 158,749.75 crore, up from Rs 138,279.30 crore in March 2024. The net profit has also increased, with Rs 12,535.75 crore reported for March 2025, up from Rs 11,148.39 crore in March 2024.

Sun Pharma

Sun Pharma's consolidated financial performance shows stability in revenue and net profit. Here’s a summary:

Consolidated Revenue (Crores):

• Jun 2024: Rs 12,652.75 Crore
• Sep 2024: Rs 13,291.39 Crore
• Dec 2024: Rs 13,675.46 Crore
• Mar 2025: Rs 12,958.84 Crore
• Jun 2025: Rs 13,851.40 Crore

The revenue for the quarter ending June 2025 was Rs 13,851.40 crore, which increased compared to June 2024, when the revenue was Rs 12,652.75 crore.

Consolidated Net Profit (Crores):

• Jun 2024: Rs 2,871.25 Crore
• Sep 2024: Rs 3,030.67 Crore
• Dec 2024: Rs 2,917.54 Crore
• Mar 2025: Rs 2,160.64 Crore
• Jun 2025: Rs 2,302.62 Crore

The net profit for the quarter ending June 2025 was Rs 2,302.62 crore, which decreased compared to June 2024, when the net profit was Rs 2,871.25 crore.

Consolidated EPS:

• Jun 2024: 11.80
• Sep 2024: 12.70
• Dec 2024: 12.10
• Mar 2025: 9.00
• Jun 2025: 9.50

The EPS for the quarter ending June 2025 was 9.50, which decreased compared to June 2024, when the EPS was 11.80.

Annual Consolidated Financials (Crores):

The company’s revenue has shown consistent growth, with revenue for the year ending March 2025 at Rs 52,578.44 crore, up from Rs 48,496.85 crore in March 2024. The net profit has also increased, with Rs 10,980.10 crore reported for March 2025, up from Rs 9,648.44 crore in March 2024.

Corporate Actions

Bharat Elec

Bharat Elec has announced several corporate actions, including notices of record dates and intimation of book closures.

The company announced a final dividend of Rs 0.90 per share (90%) with an effective date of August 14, 2025. Other recent dividends include:

• Interim Dividend: Rs 1.50 per share (150%) on March 11, 2025
• Final Dividend: Rs 0.80 per share (80%) on August 14, 2024

Bharat Elec had a bonus issue on September 15, 2022, with a bonus ratio of 2:1. The company also had a stock split on March 17, 2017.

M&M

M&M has announced corporate actions, including updates on acquisitions and transfer of equity shares.

The company announced a final dividend of Rs 25.30 per share (506%) with an effective date of July 4, 2025. Other recent dividends include:

• Final Dividend: Rs 21.10 per share (422%) on July 5, 2024
• Final Dividend: Rs 16.25 per share (325%) on July 14, 2023

M&M had a bonus issue on December 21, 2017, with a bonus ratio of 1:1. The company also had a stock split on March 29, 2010.

IndusInd Bank

IndusInd Bank has announced analyst/investor meetings.

The company announced a final dividend of Rs 16.50 per share (165%) with an effective date of June 28, 2024. Other recent dividends include:

• Final Dividend: Rs 14.00 per share (140%) on June 2, 2023
• Dividend: Rs 8.50 per share (85%) on August 11, 2022

Sun Pharma

Sun Pharma has announced analyst/investor meetings.

The company announced a final dividend of Rs 5.50 per share (550%) with an effective date of July 7, 2025. Other recent dividends include:

• Interim Dividend: Rs 10.50 per share (1050%) on February 6, 2025
• Final Dividend: Rs 5.00 per share (500%) on July 12, 2024

Sun Pharma had a bonus issue on July 29, 2013, with a bonus ratio of 1:1. The company also had a stock split on November 25, 2010.

Moneycontrol analysis indicates bearish sentiment on the stock as of August 20, 2025.

Among the Nifty 50 stocks, Bharat Elec, M&M, IndusInd Bank, Jio Financial and Sun Pharma are trading positively in today's session.